- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Aging Research
Volume 2011 (2011), Article ID 374237, 11 pages
The Ambulatory and Home Care Record: A Methodological Framework for Economic Analyses in End-of-Life Care
Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Health Sciences Building, 4th Floor, 155 College Street, Toronto, ON, Canada M5T 3M6
Received 1 October 2010; Revised 14 February 2011; Accepted 10 March 2011
Academic Editor: Laraine Winter
Copyright © 2011 Denise N. Guerriere and Peter C. Coyte. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Provision of end-of-life care in North America takes place across a multitude of settings, including hospitals, ambulatory clinics and home settings. As a result, family caregiving is characteristically a major component of care within the home. Accordingly, economic evaluation of the end-of-life care environment must devote equal consideration to resources provided by the public health system as well as privately financed resources, such as time and money provided by family caregivers. This paper addresses the methods used to measure end-of-life care costs. The existing empirical literature will be reviewed in order to assess care costs with areas neglected in this body of literature to be identified. The Ambulatory and Home Care Record, a framework and tool for comprehensively measuring costs related to the provision and receipt of end-of-life care across all health care settings, will be described and proposed. Finally, areas for future work will be identified, along with their potential contribution to this body of knowledge.
Health care restructuring in North America has resulted in an increased emphasis on ambulatory and home-based end-of-life care . Home-based healthcare services are characterized by limited resources and escalating healthcare costs. In some areas, publicly financed home-based end-of-life programs have been established to provide community care and team-based multidisciplinary care to individuals at home. While the home environment is often the first choice for patients and family members, home-based care may place higher demands on family members, particularly when a patient has complex and immediate health care needs and is close to death.
Although a high proportion of home-based end-of-life care is provided by family caregivers, little empirical attention has been devoted to the identification and measurement of the full range of costs incurred by patients and their caregivers. Most economic analyses of home-based care are limited to measurement of publicly financed care. Despite the fact that a high proportion of end-of-life care is provided by family caregivers, particularly in the home setting, time spent by these caregivers is often perceived as having no or minimal monetary value . Time allocations to care, if not provided by family caregivers, may have necessitated the acquisition of a privately funded caregiver. Measuring only health system costs, whether publicly or privately financed, may therefore lead to an inaccurate estimate of relative resource costs associated with alternative health care settings or interventions, particularly when family costs represent a large portion of overall costs.
In this paper, we discuss the methodological aspects of end-of-life care costs. Methodological elements of the empirical literature will be presented and areas that have been neglected in this body of literature will be identified. We present the Ambulatory and Home Care Record (AHCR), a framework and tool to inform future research that measures end-of-life care costs from a societal perspective [2–4]. Measuring costs from a societal perspective dictates that all resource costs, irrespective of payer, be considered. Finally, research areas that can be addressed using the AHCR methodological framework and tool will be identified and the potential contribution of these suggested topics will be provided.
2. Economic Empirical Studies on End-of-Life Care
The economic research literature on end-of-life care has been dominated by studies measuring publicly financed health services; few studies have examined costs incurred by patients and their caregivers. Excluding patient and caregiver resource costs in studies comparing home-based care to in-patient care results in underestimates of the value, types, and sources of resources consumed in various health care settings. The absence of information on the costs of an episode of end-of-life care limits health planning and may unduly restrict access to such services if managers and/or clinicians overestimate these costs or if there is significant uncertainty in such cost estimates.
Measuring privately financed resources and time devoted to caregiving is essential because the work dedicated by family members in the home environment is intense, particularly as the patient nears death [5–10]. Several empirical studies have indicated that families report end-of-life caregiving to be psychosocially demanding [9–24] and financially straining [9, 10, 12, 21, 23, 25–27]. Measurement of family member costs is difficult for a number of reasons. Research in this area is costly as it requires prospective design to accurately assess caregiver time and costs. Furthermore, recruitment of caregiver participants is particularly challenging as many caregivers are already overtaxed caring for their terminally ill family member, thus less likely to agree to participate, and consequently, those that do participate are likely to be ones that experience less intensive caregiving responsibilities. However, excluding patient and caregiver resource costs in such studies underestimates the value and type of resources consumed in various health care settings, thus it is important that studies are designed in such a way to overcome and minimize these barrier and potential biases.
A systematic literature review was conducted to identify original studies that have assessed economic outcomes in end-of-life care. PubMed and MEDLINE were searched (period = 1998–2009). The key word terms used were “Palliative care” AND “costs” AND [“terminal care” OR “utilization” OR “financial outcomes” OR “hospice” OR “home care”]. In addition, several journals that were directly relevant to the topic were also examined. Finally, a snowballing technique was implemented whereby references cited in the relevant articles were examined and included if they proved relevant to the research topic. Articles were excluded from search results if not specific to end-of-life care, if cost measurement was not the primary focus, or if cost analysis was limited to a particular component of palliative care (e.g., specific treatment, specific service use). This search strategy resulted in the identification of 18 studies investigating economic outcomes of end-of-life care. We approach our discussion of these studies herein by identifying which cost categories have been considered; these studies are represented in Table 1.
Most studies that measured in-patient costs attributable to end-of-life care have been designed to assess cost savings associated with the implementation of new in-patient end-of-life care programs [31, 32, 37, 39] or interventions [28, 30, 33, 36]. These studies captured only public costs from a health system perspective and over a relatively short period from hospital admission until death. In contrast, Oliver and colleagues  conducted a more complete assessment of the in-patient costs of all hospitalizations from the time of initial cancer diagnosis until death. Although this study provided insight into hospital costs at various points over the illness trajectory, it did not capture home and ambulatory costs between hospitalizations and it did not address out-of-pocket or time costs borne by patients and their families/friends.
Studies which have assessed the cost of home-based end-of-life care have either compared home-based programs to institutionally based end-of-life care or to regular home-based care [3, 4, 29, 38], looked at changes in costs after the introduction of home-based end-of-life care programs , or measured costs of a home-based palliative care program . Only one of these six studies that exclusively measured home-based health system costs included all aspects of public system expenditures ; however, an important component of overall costs (i.e., private costs) was excluded. In three studies, only staff time dedicated to end-of-life care was included and other health system costs, such as laboratory/diagnostic tests [3, 29, 40] and medications [3, 29] were excluded. One pilot study measured all public expenditures of ambulatory health system costs associated with a home-based palliative program, but did not include private expenditures . In addition, in one study, health system costs were measured by assessing budgeted resource use prior to the implementation of a home-based program . As these six studies only emphasize public health system costs, they underestimate the full range of economic costs incurred. Out-of-pocket expenditures for medications, care providers, and travel expenses, as well as time costs associated with the receipt and provision of formal and informal health care services may be substantial contributors to overall costs.
In two other studies, both public and private costs associated with home-based end-of-life care were measured [5, 6]; however, not all relevant components were captured. In both of these studies, system costs were comprehensively measured along with families’ out-of-pocket health care expenses. One assessed only privately financed appointments and out-of-pocket costs , while the other measured only out-of-pocket costs and labor market time losses . Since time lost from household work or leisure was not assessed, the full economic contribution of caregivers to home-based end-of-life care was not captured.
One recently published study assessed both hospital and home-based end-of-life care costs from a societal perspective in five different regions across Canada . Although this study provides insight into end-of-life care costs, there were two categories that were not captured. Time missed from the labour market was not captured, leaving lost income for caregivers as well as costs incurred by employers missing. Furthermore, this study did not assess resource costs covered by third party insurance. In addition, caregivers’ time devoted to caregiving was measured by asking respondents to report an estimate of a typical day over the past 2 weeks, not allowing for variation in caregivers’ during the two-week period.
None of the aforementioned studies utilized an instrument that had been standardized and evaluated. As in all aspects of methodology, the use of a standardized and evaluated questionnaire supports the validity and reliability of the study results.
3. Framework for Measuring Home-Based End-of-Life Costs
We propose the use of the Ambulatory and Home Care Record (AHCR), a standardized and comprehensive framework and tool, to measure costs within the end-of-life context from a societal perspective [2–4] (see Appendix). This approach gives equal consideration to costs borne by the health system as well as those costs borne by care recipients and informal caregivers, such as family members and friends. This perspective values out-of-pocket expenses as well as time devoted to caregiving [36, 41]. The importance given to such caregiving time is based on the premise that such time may have been used in other activities such as market labour, leisure, or household work, and hence represent foregone opportunities . This is considered a major advantage given that time costs can represent a significant proportion of total healthcare costs .
The AHCR was developed in 1997 by the authors in response to the gaps and inconsistency of systematic economic evaluations in assessing health system costs associated with ambulatory and home-based health services. Items for the questionnaire were determined through research with economics literature and focus groups with health economists, health care professionals, and patients within both pediatric and adult settings. Its content validity was further evaluated with a panel of experts and revisions were made accordingly.
The AHCR is designed as a prospective tool which can be self-administered or completed in a face-to-face or telephone interview. An electronic version of the AHCR has been developed to facilitate real-time data entry and to expedite the valuation process. The psychometric properties of the AHCR in collecting publicly financed health services was evaluated with a cohort of cystic fibrosis patients where prospective self-administered AHCR reports were compared with administrative data; agreement ranged from moderate to perfect (kappa −0.41–1.0) . Since inception, the AHCR has been used for a range of clients by age, care setting, and clinical condition, and in several countries [42, 44–58]. Items in the AHCR are categorized as publicly financed expenditures or privately financed expenditures (Table 2). Publicly financed expenditures include all costs incurred by the public sector in the organization and delivery of health care services. Public expenditures comprise those costs associated with the use of ambulatory services, in-patient services, and home-based health services. Privately financed care includes all health care costs not publicly insured and/or financed. This includes third party insurance payments, out-of-pocket payments by patients and their families/friends, time costs incurred by family caregivers, and costs to employers when caregivers are absent from the workplace. Third party insurance refers to the amount of money paid by insurance companies to cover healthcare services. Private health insurance can be paid for by employers or paid for by patients/families if they purchase it themselves. Out-of-pocket costs include the amount of money paid by families for consultations with healthcare professionals (not covered by public funding), household help, medications, supplies, travel expenses, and private insurance expenditures. Caregiver time costs refer to the monetary value assigned to time losses incurred by unpaid caregivers in relation to the patient’s care (e.g., time spent caring for the patient, time spent traveling to and from consultations). This lost time is quantified in economic terms by assigning a monetary value to lost time.
To value end-of-life resources, we access various sources. Fee-for-service rate schedules are used to determine physician and laboratory service unit costs. Rates used for resource expenditures by the relevant home care agencies are employed to determine the cost of publicly financed home-based provider services. Medication costs paid for by the government are derived using the public drug insurance formulary rate. Out-of-pocket costs incurred by families are self-reported and any reimbursements received from drug plans or medical insurance are subtracted from these expenses. Hospitalizations are assigned to designated case mix groups [59, 60], and valued in accordance with associated resource intensity weights [61–63]. Finally, time costs are assigned a monetary value using the human capital approach . This approach applies current average earnings by age and gender to lost market time and imputes the market value of time withdrawn from leisure and household work. To value time lost from market labor, age-/sex- based earnings estimates from the National Census are used and adjusted for employer paid benefits and vacation days and holidays. Time lost from household work/leisure is valued using the estimated earnings of a homemaker from the National Census and adjusted for fringe benefits, and vacation days and holidays. Consequently, the valuation of time lost is dependent on the sources of such caregiving time, that is, whether time is diverted from the labour market, household work or leisure.
The AHCR has been used to evaluate two aspects of end-of-life care and published in the literature . First, costs associated with a home-based end-of-life program in two provinces in Canada  were assessed over the end-of-life care trajectory, from time of admission into the program until death. Second, data from the AHCR was used to assess the predictors of place of death (home versus institution) within a sample of patients enrolled in a home-based program in Toronto . Based on this data and consideration of the extensive needs of the end-of-life care discipline [21, 65–68], below we recommend a multitude of economic research topics that require further study and their importance.
It should be noted that other standardized costing tools for use in medical patients are available. However, these tools have not been developed in the context of end-of-life care, thus pose several limitations for economic studies of terminally ill palliative care patients.
4. Uses of Economic Outcome Data Generated by the AHCR Framework
There are five main ways in which the AHCR methodological framework can be utilized to assess the end-of-life care environment. These approaches are discussed in the five sections below. The ACHR can be partnered with other data collection instruments to ascertain a comprehensive assessment of the overall home-based end-of-life environment, and such data may be analyzed in a multitude of ways to describe the economic context within which care is provided. We provide suggestions as to what types of questions can be answered using this framework, while providing some examples of our previous work, and how the information may be used to inform practice.
4.1. Cost Category Comparisons
The data generated by the AHCR can allow for a patient-level analysis. Each participant’s responses to the AHCR yield four subsets of resource costs: (1) publicly financed health system costs, (2) private third party insurance expenditures, (3) privately financed out-of-pocket costs, and (4) private time costs. The four cost categories can also be aggregated to yield total societal costs. Assessments of and comparisons with other end-of-life interventions and programs is feasible; comparisons can be made between total societal cost and between subsets of resource costs. Previous applications of the AHCR have revealed that patient and family costs comprised a large portion (from 65% to 72%) of the total costs associated with ambulatory and home-based care [42, 47–56]. Although these previous studies were conducted with patients/families with a variety of chronic and acute conditions, these findings highlight the important contribution of time costs to overall costs in caregiving environments.
4.2. Private/Public Relationship
Measuring all relevant cost categories in the end-of-life care context allows for the examination of the relationship between private and public expenditure and the determination of whether they substitute or complement each other. In addition, it is possible to examine the proportion of total costs associated with the key end-of-life care components such as physician visits, nurse visits, personal support worker visits, ambulatory physician appointments, and other home-based and ambulatory appointments. This type of analysis would permit health service planning and resource allocation within programs and across sites of care.
4.3. Temporal Cost Assessment
A prospective approach to measuring costs allows for a longitudinal assessment over the care trajectory. A comprehensive assessment of private and public costs of both home and institutional costs over the entire end-of-life care trajectory allows for an understanding of how costs change over time, how they behave as patients near death, and how possible changes in the intensity of care provision might modify outcomes, such as place of death, quality of life for patients and caregivers, and overall costs of the episode of care. In our previous work, we found that costs increased exponentially as the care recipient approached death . Because caregivers provide a significant amount of care and are responsible for coordinating home-based care, it is essential to obtain an understanding of the care environment in order to ensure that they are being supported in their efforts. By characterizing the distribution of societal costs, insight into the financial burden experienced by families throughout the end-of-life care trajectory can be obtained. Such information offers the potential to gauge the relationship between family caregiving activities and various other cost components. Findings from this may be used to identify a role for caregiving allowances and other forms of caregiver support. This temporal assessment of costs has the potential to inform policy as aspects of care may be appropriately modified at each time point in the end-of-life care trajectory.
4.4. Cost Predictors
The AHCR methodological framework also permits the examination of factors that predict public and private resource utilization. Specifically, the sociodemographic and clinical factors that predict the propensity and intensity of end-of-life service use and what predictors are important at different times in the trajectory can be examined. For example, in our previous work, we found that age, gender, living arrangement, activities of daily living (ADL), number of chronic conditions, and the interaction between both public expenditure and ADL level were shown to increase private expenditures . Furthermore, in another study, we assessed predictors of end-of-life costs . Three variables were found to be significant predictors of total costs: time to death, functional status, and living arrangement. Total societal costs increased as time to death decreased. This observation was expected because as patients near death, their care needs increase, and consequently their use of resources increases. Patients who had poorer functional status incurred greater total costs compared with those with better functional status. This was expected because as a patients’ level of functioning falls, he/she requires more care, thereby increasing resource costs. Patients who lived alone had lower total costs than those who lived with others. It is postulated that these higher costs are attributable to having a caregiver who is more accessible to provide care, relative to those not living with their caregiver.
4.5. Standardized Method for Economic Evaluation
Systematic evaluation of the costs associated with the provision and receipt of ambulatory and home-based health services is an essential component of research aimed at determining which interventions and sites of care are most cost-effective. The AHCR is a standardized resource and costing tool that enables accurate comparisons of the resource implications for different services and for diverse patients. Application of AHCR methods would enhance the efficiency with which scarce resources in the area of end-of-life care are allocated.
The AHCR was developed in response to the need for a standardized, comprehensive instrument to obtain and value resources associated with ambulatory and home-based health programs. The AHCR allows for a greater appreciation of the differences in end-of-life care costs between home and hospital based services, and the relationship between public and private expenditures. Application of the AHCR, when used in conjunction with quality of life, caregiver burden, and performance scales, can provide information that will gauge the relationship between family caregiving activities and other cost components within the home setting. Issues concerning access to services, as well as their quantity and quality can be highlighted. Understanding cost implications may inform the targeting of services to those patients and their families. By measuring costs longitudinally we can observe changes over end-of-life care trajectory. This knowledge will indicate areas for resource shifting and potential cost savings.
A lack of research in economic outcomes in end-of-life care impedes informed decision-making by practitioners, health managers, and policy decisions makers; it may give rise to insufficient levels of financial support for patients and caregivers when programs are unable to be transparent and accountable for resources expended. AHCR findings will help senior administrators and managers in monitoring resource costs and the quality of home-based end-of-life care. This framework can greatly benefit: practitioners and health managers of community-based end-of-life care teams who aim to meet health and social care needs of patients; managers at regional and local level who are responsible for resource allocation, program design, and quality improvement; or policy decision makers engaged in program evaluation, funding decisions, and who are responding to the need for accountability.
Ambulatory and Home Care Record Coyte and Guerriere 1998
(1) Health Care Appointments at Home [Does not Include Any Health Care Professionals You Paid]
Which health care professionals visited the patient at home in the past two weeks, from [Start of interview period] to [End of interview period]? (see Table 3).
(2) Health Care Appointments Outside the Home
Did the patient see a health care professional outside of the home, from [Start of interview period] to [End of interview period]? (see Table 4).
(3) Care to the Patient by Paid Care Providers
Did you (or another family member) pay money to anyone to care for the patient at home, from [Start of interview period] to [End of interview period]? (see Table 5).
Did you (or another family member) buy or receive supplies/equipment or buy medicine (prescription or over-the-counter) for the patient, from [Start of interview period] to [End of interview period]? (see Table 6).
(5) Care to the Patient [Provided by You, Another Family Member, Friend, Neighbour [Does not Include Anyone You Paid]
What is the total number of hours you and your family and other caregivers spent caring for the patient, from [Start of interview period] to [End of interview period]? (see Table 7).
- P. C. Coyte and P. McKeever, “Home care in Canada: passing the buck,” Canadian Journal of Nursing Research, vol. 33, no. 2, pp. 11–25, 2001.
- K. Fassbender, R. Fainsinger, C. Brenneis, P. Brown, T. Braun, and P. Jacobs, “Utilization and costs of the introduction of system-wide palliative care in Alberta, 1993–2000,” Palliative Medicine, vol. 19, no. 7, pp. 513–520, 2005.
- R. D. Brumley, S. Enguidanos, and D. A. Cherin, “Effectiveness of a home-based palliative care program for end-of-life,” Journal of Palliative Medicine, vol. 6, no. 5, pp. 715–724, 2003.
- E. Bruera, C. M. Neumann, B. Gagnon, C. Brenneis, H. Quan, and J. Hanson, “The impact of a regional palliative care program on the cost of palliative care delivery,” Journal of Palliative Medicine, vol. 3, no. 2, pp. 181–186, 2000.
- Y. Shnoor, M. Szlaifer, A. S. Aoberman, and N. Bentur, “The cost of home hospice care for terminal patients in Israel,” American Journal of Hospice and Palliative Medicine, vol. 24, no. 4, pp. 284–290, 2007.
- A. T. C. Chan, P. Jacobs, W. Yeo et al., “The cost of palliative care for hepatocellular carcinoma in Hong Kong,” PharmacoEconomics, vol. 19, no. 9, pp. 947–953, 2001.
- S. Dumont, P. Jacobs, K. Fassbender, D. Anderson, V. Turcotte, and F. Harel, “Costs associated with resource utilization during the palliative phase of care: a Canadian perspective,” Palliative Medicine, vol. 23, no. 8, pp. 708–717, 2009.
- D. N. Guerriere, B. Zagorski, K. Fassbender, L. Masucci, L. Librach, and P. C. Coyte, “Cost variations in ambulatory and home-based palliative care,” Palliative Medicine, vol. 24, no. 5, pp. 523–532, 2010.
- S. M. Aoun, L. J. Kristjanson, D. C. Currow, and P. L. Hudson, “Caregiving for the terminally ill: at what cost?” Palliative Medicine, vol. 19, no. 7, pp. 551–555, 2005.
- S. Jo, K. Brazil, L. Lohfeld, and K. Willison, “Caregiving at the end of life: perspectives from spousal caregivers and care recipients,” Palliative & Supportive Care, vol. 5, no. 1, pp. 11–17, 2007.
- A. Z. Doorenbos, B. Given, C. W. Given et al., “The influence of end-of-life cancer care on caregivers,” Research in Nursing and Health, vol. 30, no. 3, pp. 270–281, 2007.
- E. J. Emanuel, D. L. Fairclough, J. Slutsman, and L. L. Emanuel, “Understanding economic and other burdens of terminal illness: the experience of patients and their caregivers,” Annals of Internal Medicine, vol. 132, no. 6, pp. 451–459, 2000.
- E. Grunfeld, D. Coyle, T. Whelan et al., “Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers,” Canadian Medical Association Journal, vol. 170, no. 12, pp. 1795–1801, 2004.
- S. S. Hwang, V. T. Chang, Y. Alejandro et al., “Caregiver unmet needs, burden, and satisfaction in symptomatic advanced cancer patients at a Veterans Affairs (VA) medical center,” Palliative & supportive care., vol. 1, no. 4, pp. 319–329, 2003.
- Y. Kim and R. Schulz, “Family caregivers' strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving,” Journal of Aging and Health, vol. 20, no. 5, pp. 483–503, 2008.
- S. J. Marwit, J. T. Chibnall, R. Dougherty, C. Jenkins, and J. Shawgo, “Assessing pre-death grief in cancer caregivers using the Marwit-Meuser Caregiver Grief Inventory (MM-CGI),” Psycho-Oncology, vol. 17, no. 3, pp. 300–303, 2008.
- Y.S. Rhee, Y. H. Yun, S. Park et al., “Depression in family caregivers of cancer patients: the feeling of burden as a predictor of depression,” Journal of Clinical Oncology, vol. 26, no. 36, pp. 5890–5895, 2008.
- B. Given, G. Wyatt, C. Given et al., “Burden and depression among caregivers of patients with cancer at the end of life,” Oncology Nursing Forum, vol. 31, no. 6, pp. 1105–1117, 2004.
- L. C. Vanderwerker, R. E. Laff, N. S. Kadan-Lottick, S. McColl, and H. G. Prigerson, “Psychiatric disorders and mental health service use among caregivers of advanced cancer patients,” Journal of Clinical Oncology, vol. 23, no. 28, pp. 6899–6907, 2005.
- S. Dumont, J. Turgeon, P. Allard, P. Gagnon, C. Charbonneau, and L. Vézina, “Caring for a loved one with advanced cancer: determinants of psychological distress in family caregivers,” Journal of Palliative Medicine, vol. 9, no. 4, pp. 912–921, 2006.
- S. Zapart, P. Kenny, J. Hall, B. Servis, and S. Wiley, “Home-based palliative care in Sydney, Australia: the carer's perspective on the provision of informal care,” Health and Social Care in the Community, vol. 15, no. 2, pp. 97–107, 2007.
- J. E. Gaugler, N. Hanna, J. Linder et al., “Cancer caregiving and subjective stress: a multi-site, multi-dimensional analysis,” Psycho-Oncology, vol. 14, no. 9, pp. 771–785, 2005.
- D. Bainbridge, P. Krueger, L. Lohfeld, and K. Brazil, “Stress processes in caring for an end-of-life family member: application of a theoretical model,” Aging and Mental Health, vol. 13, no. 4, pp. 537–545, 2009.
- S. Dumont, L. Fillion, P. Gagnon, and N. Bernier, “A new tool to assess family caregivers' burden during end-of-life care,” Journal of Palliative Care, vol. 24, no. 3, pp. 151–161, 2008.
- K. Brazil, D. Bainbridge, and C. Rodriguez, “The stress process in palliative cancer care: a qualitative study on informal caregiving and its implication for the delivery of care,” American Journal of Hospice and Palliative Medicine, vol. 27, no. 2, pp. 111–116, 2010.
- B. Hanratty, P. Holland, A. Jacoby, and M. Whitehead, “Financiai stress and strain associated with terminal cancer—a review of the evidence,” Palliative Medicine, vol. 21, no. 7, pp. 595–607, 2007.
- V. P. Tilden, S. W. Tolle, L. L. Drach, and N. A. Perrin, “Out-of-hospital death: advance care planning, decedent symptoms, and caregiver burden,” Journal of the American Geriatrics Society, vol. 52, no. 4, pp. 532–539, 2004.
- B. Axelsson and S. B. Christensen, “Evaluation of a hospital-based palliative support service with particular regard to financial outcome measures,” Palliative Medicine, vol. 12, no. 1, pp. 41–49, 1998.
- R. Brumley, S. Enguidanos, P. Jamison et al., “Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care,” Journal of the American Geriatrics Society, vol. 55, no. 7, pp. 993–1000, 2007.
- J. D. Cowan, “Hospital charges for a community inpatient palliative care program,” American Journal of Hospice and Palliative Medicine, vol. 21, no. 3, pp. 177–190, 2004.
- A. Elsayem, K. Swint, M. J. Fisch et al., “Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes,” Journal of Clinical Oncology, vol. 22, no. 10, pp. 2008–2014, 2004.
- X. Gómez-Batiste, A. Tuca, E. Corrales et al., “Resource consumption and costs of palliative care services in Spain: a multicenter prospective study,” Journal of Pain and Symptom Management, vol. 31, no. 6, pp. 522–532, 2006.
- L. C. Hanson, B. Usher, L. Spragens, and S. Bernard, “Clinical and economic impact of palliative care consultation,” Journal of Pain and Symptom Management, vol. 35, no. 4, pp. 340–346, 2008.
- A. P. Johnson, T. Abernathy, D. Howell, K. Brazil, and S. Scott, “Resource utilisation and costs of palliative cancer care in an interdisciplinary health care model,” Palliative Medicine, vol. 23, no. 5, pp. 448–459, 2009.
- E. Oliver, J. Killen, G. Kiebert et al., “Treatment pathways, resource use and costs in the management of small cell lung cancer,” Thorax, vol. 56, no. 10, pp. 785–790, 2001.
- J. D. Penrod, P. Deb, C. Luhrs et al., “Cost and utilization outcomes of patients receiving hospital-based palliative care consultation,” Journal of Palliative Medicine, vol. 9, no. 4, pp. 855–860, 2006.
- T. J. Smith, P. Coyne, B. Cassel, L. Penberthy, A. Hopson, and M. A. Hager, “A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs,” Journal of Palliative Medicine, vol. 6, no. 5, pp. 699–705, 2003.
- O. Tamir, Y. Singer, and P. Shvartzman, “Taking care of terminally-ill patients at home—the economic perspective revisited,” Palliative Medicine, vol. 21, no. 6, pp. 537–541, 2007.
- K. R. White, K. G. Stover, J. B. Cassel, and T. J. Smith, “Nonclinical outcomes of hospital-based palliative care,” Journal of Healthcare Management, vol. 51, no. 4, pp. 260–273, 2006.
- S. L. Hughes, J. Cummings, F. Weaver, L. Manheim, B. Braun, and K. Conrad, “A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill,” Health Services Research, vol. 26, no. 6, pp. 801–817, 1992.
- P. Cantwell, S. Turco, C. Brenneis, J. Hanson, C. M. Neumann, and E. Bruera, “Predictors of home death in palliative care cancer patients,” Journal of Palliative Care, vol. 16, no. 1, pp. 23–28, 2000.
- D. N. Guerriere, A. Y. M. Wong, R. Croxford, V. W. Leong, P. McKeever, and P. C. Coyte, “Costs and determinants of privately financed home-based health care in Ontario, Canada,” Health and Social Care in the Community, vol. 16, no. 2, pp. 126–136, 2008.
- D. N. Guerriere, W. J. Ungar, M. Corey et al., “Evaluation of the ambulatory and home care record: agreement between self-reports and administrative data,” International Journal of Technology Assessment in Health Care, vol. 22, no. 2, pp. 203–210, 2006.
- M. Gold, J. E. Siegel, L. B. Russel, and M. C. Weinstein, Cost-Effectiveness in Health and Medicine, Oxford University Press, New York, NY, USA, 1996.
- M. Drummond, B. O'Brien, G. L. Stoddart, and G. W. Torrance, Methods for the Economic Evaluation of Health Care Programmes, Oxford University Press, Toronto, Canada, 1997.
- B. Yates, Analyzing Costs, Procedures, Processes, and Outcomes in Human Service, Sage Publications, Calif, USA, 1997.
- S. LeForte, J. Watt-Watson, K. Gray-Donald, K. Webber, P. C. Coyte, and D. N. Guerriere, Evaluation of the Chronic Pain Self-Management Program, Canadian Institutes of Health Research.
- J. E. Tranmer, D. N. Guerriere, W. J. Ungar, and P. C. Coyte, “Valuing patient and caregiver time: a review of the literature,” PharmacoEconomics, vol. 23, no. 5, pp. 449–459, 2005.
- V. Leong, D. N. Guerriere, R. Croxford, and P. C. Coyte, “The magnitude, share and determinants of private costs incurred by recipients (and their caregivers) of in-home publicly financed care,” Healthcare Policy, vol. 11, no. 8, 2007.
- M. McGillion, R. Croxford, J. Watt-Watson, S. LeFort, B. Stevens, and P. Coyte, “Cost of illness for chronic stable angina patients enrolled in a self-management education trial,” Canadian Journal of Cardiology, vol. 24, no. 10, pp. 759–764, 2008.
- P. C. Coyte, E. Jamieson, N. Mulkovich, et al., An Economic Evaluation of Hospital-Based and Home-Based Antibiotic Intravenous Therapy for Individuals with Cellulites, Health Transition Fund.
- B. Stevens, D. Guerriere, P. McKeever et al., “Economics of home vs. hospital breastfeeding support for newborns,” Journal of Advanced Nursing, vol. 53, no. 2, pp. 233–243, 2006.
- N. L. Young, W. Barden, S. Lefort et al., “Telehomecare: a comparison of three Canadian models,” Telemedicine Journal and e-Health, vol. 10, no. 1, pp. 45–52, 2004.
- K. G. D. Hadden, Global and Molecular Pain Response in Children with and without Significant Neurological Impairment, Canadian Institutes of Health Research.
- D. N. Guerriere, M. Choinière, D. Dion et al., “The Canadian STOP-PAIN project—part 2: what is the cost of pain for patients on waitlists of multidisciplinary pain treatment facilities?” Canadian Journal of Anesthesia, vol. 57, no. 6, pp. 549–558, 2010.
- A. Tsimicalis, B. Stevens, W. Ungar, et al., Costs incurred by families of children newly diagnosed with cancer, Ph.D. thesis, Department of Nursing, University of Toronto, Toronto, Canada.
- L. Masucci, D. N. Guerriere, R. Cheng, and P. C. Coyte, “Determinants of place of death for recipients of home-based palliative care,” Journal of Palliative Care, vol. 26, no. 4, pp. 279–286, 2010.
- W. Isaranuwatchai, D. N. Guerriere, G. Andrews, and P. C. Coyte, Patterns, determinants, and spatial analysis of health service utilization following the 2004 tsunami in Thailand, Ph.D. thesis, Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
- J. Sutherland, “ICD-10-based Relative Cost Weights,” PAC-10, 2004.
- Canadian Institute for Health Information (CIHI), Discharge Abstract Database (DAD) Resource Intensity Weights and Expected Length of Stay 2005, CIHI, Ottawa, Canada, 2005.
- Canadian Institute of Health Information (CIHI), Canadian Classification of Health Interventions (CCI).
- Canadian Institute for Health Information (CIHI), International Statistical Classification of Diseases and Related Health Problems Tenth Revision Canada (ICD-10-CA).
- Canadian Institute for Health Information (CIHI), CMG/Plx Directory 2002 (for use with ICD-10-CA/CCI), CIHI, Ottawa, Canada, 2002.
- D. J. Torgerson, C. Donaldson, and D. M. Reid, “Private versus social opportunity cost of time: valuing time in the demand for health care,” Health Economics, vol. 3, no. 3, pp. 149–155, 1994.
- M. W. Rabow, J. M. Hauser, and J. Adams, “Supporting family caregivers at the end of life: “They Don't Know What They Don't Know”,” Journal of the American Medical Association, vol. 291, no. 4, pp. 483–491, 2004.
- B. H. P. Osse, M. J. F. J. Vernooij-Dassen, E. Schadé, and R. P. T. M. Grol, “Problems experienced by the informal caregivers of cancer patients and their needs for support,” Cancer Nursing, vol. 29, no. 5, pp. 378–388, 2006.
- K. Brazil, M. Bédard, K. Willison, and M. Hode, “Caregiving and its impact on families of the terminally ill,” Aging and Mental Health, vol. 7, no. 5, pp. 376–382, 2003.
- J. L. Wolff, S. M. Dy, K. D. Frick, and J. D. Kasper, “End-of-life care: findings from a national survey of informal caregivers,” Archives of Internal Medicine, vol. 167, no. 1, pp. 40–46, 2007.